Tacalyx

Glycan excellence against cancer

Berlin, Germany · Founded 2019 · $28.1M raised

Headquarters
Berlin
Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$28.1M
Last Round
$13.0M Extension RoundApr 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 11 investors for this company. The full record is or through the API.

About

Tacalyx is a Berlin-based biotech company founded in 2019 as a spin-out of the Max-Planck-Institute of Colloids and Interfaces (MPICI) in Potsdam, Germany. The company develops novel anticancer therapeutics targeting Tumor Associated Carbohydrate Antigens (TACAs) — carbohydrate structures highly expressed on tumor cells but not in healthy differentiated tissues. Tacalyx's pipeline includes antibody-drug conjugates (ADCs) and other immunotherapeutics targeting TACAs, with its lead TCX-201 programme advancing toward clinical trials after a €11 million funding round in April 2026. Tacalyx is backed by High-Tech Gründerfonds, Kurma Partners, Boehringer Ingelheim Venture Fund, Creathor Ventures, and Max-Planck-Innovation.

Summary

Tacalyx is a Biotech company based in Berlin, Germany, founded in 2019. It has raised $28.1M in total across 2 rounds, most recently a $13.0M Extension Round in Apr 2026. Investors include Boehringer Ingelheim Venture Fund, Thuja Capital and Kurma Partners.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundExtension RoundApr 2026
$13.0M

Sign up to see all 2 events

Funding: Seed through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Tacalyx on Indexed.vc
<a href="https://indexed.vc/companies/tacalyx"><img src="https://indexed.vc/api/badge/company/tacalyx" alt="Tacalyx on Indexed.vc" width="260" height="76" /></a>